Parameshwar Makam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Parameshwar Makam has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Dattatraya Raut
Organic Chemistry Research Laboratory School of Chemical Sciences Solapur University Solapur, Maharashtra 413255 India
3 shared publicationsMahesh Hublikar
Organic Chemistry Research Laboratory School of Chemical Sciences Solapur University Solapur, Maharashtra 413255 India
3 shared publications- Naresh Kumar Katari
School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus University of KwaZulu‐Natal Durban South Africa
3 shared publications - Rambabu Gundla
Department of Chemistry, School of Science, GITAM University, Hyderabad 502102, Telangana, India
3 shared publications Sachin Shirame
Organic Chemistry Research Laboratory School of Chemical Sciences Solapur University Solapur, Maharashtra 413255 India
3 shared publications- Balakrishna Kolli
Department of Chemistry, School of Science, GITAM (Deemed to be University), Vishakhapatnam-530045, India
2 shared publications
Latest Publications
- 24 September 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (11) , e202400844
Design, Synthesis, Anti‐Cancer, Anti‐Inflammatory and In Silico Studies of 3‐Substituted‐2‐Oxindole Derivatives
This study focuses on the design and synthesis of 3‐substituted‐2‐oxindole derivatives aimed at developing dual‐active molecules with anti‐cancer and anti‐inflammatory properties. The molecules were designed with diverse structural and functional features while adhering to Lipinski, Veber, and Leeson criteria. Physicochemical properties were assessed using SWISSADME to ensure drug‐likeness and favourable pharmacokinetics. Multistep synthetic procedures were employed for molecule synthesis. In vitro evaluations confirmed the dual activity of the derivatives, with specific emphasis on the significance of dialkyl aminomethyl substitutions for potency against various cell lines. 4 a exhibited GI50 value 3.00E−05 against MDA‐MB‐231, 4 b has shown GI50 value 2E−05 against MDA‐MB‐231, 4 c has shown GI50 value 6E−05 against VERO, 4 d has shown GI50 value 8E−05 each against both the MDA‐MB‐231 and MCF‐7 and 4 e has shown GI50 values 2E−05 and 5E−05 each against both the MCF‐7 and VERO. The analysis indicates that compounds 3 c (71.19 %), 3 e (66.84 %), and 3 g (63.04 %) exhibited significant anti‐inflammatory activity. Additionally, in silico binding free energy analysis and interaction studies revealed significant correlations between in vitro and computational data, identifying compounds 4 d, 4 e, 3 b, 3 i, and 3 e as promising candidates. Key residues such as Glu917, Cys919, Lys920, Glu850, Lys838, and Asp1046 were found to play critical roles in ligand binding and kinase inhibition, providing valuable insights for designing potent VEGFR2 inhibitors. The Quantum Mechanics‐based Independent Gradient Model analysis further highlighted the electronic interaction landscape, showing larger attractive peaks and higher electron density gradients for compounds 4 d and 4 e compared to Sunitinib, suggesting stronger and more diverse attractive forces. These findings support the potential of these compounds for further development and optimization in anticancer drug design.
- 24 September 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (11) , e202400844
Design, Synthesis, Anti‐Cancer, Anti‐Inflammatory and In Silico Studies of 3‐Substituted‐2‐Oxindole Derivatives
This study focuses on the design and synthesis of 3‐substituted‐2‐oxindole derivatives aimed at developing dual‐active molecules with anti‐cancer and anti‐inflammatory properties. The molecules were designed with diverse structural and functional features while adhering to Lipinski, Veber, and Leeson criteria. Physicochemical properties were assessed using SWISSADME to ensure drug‐likeness and favourable pharmacokinetics. Multistep synthetic procedures were employed for molecule synthesis. In vitro evaluations confirmed the dual activity of the derivatives, with specific emphasis on the significance of dialkyl aminomethyl substitutions for potency against various cell lines. 4 a exhibited GI50 value 3.00E−05 against MDA‐MB‐231, 4 b has shown GI50 value 2E−05 against MDA‐MB‐231, 4 c has shown GI50 value 6E−05 against VERO, 4 d has shown GI50 value 8E−05 each against both the MDA‐MB‐231 and MCF‐7 and 4 e has shown GI50 values 2E−05 and 5E−05 each against both the MCF‐7 and VERO. The analysis indicates that compounds 3 c (71.19 %), 3 e (66.84 %), and 3 g (63.04 %) exhibited significant anti‐inflammatory activity. Additionally, in silico binding free energy analysis and interaction studies revealed significant correlations between in vitro and computational data, identifying compounds 4 d, 4 e, 3 b, 3 i, and 3 e as promising candidates. Key residues such as Glu917, Cys919, Lys920, Glu850, Lys838, and Asp1046 were found to play critical roles in ligand binding and kinase inhibition, providing valuable insights for designing potent VEGFR2 inhibitors. The Quantum Mechanics‐based Independent Gradient Model analysis further highlighted the electronic interaction landscape, showing larger attractive peaks and higher electron density gradients for compounds 4 d and 4 e compared to Sunitinib, suggesting stronger and more diverse attractive forces. These findings support the potential of these compounds for further development and optimization in anticancer drug design.
- 2 July 2024
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 101 (9)
Chiral (S)-BINOL-phosphates: Design, synthesis and their antibacterial and α-glucosidase inhibition studies
- 2 July 2024
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 101 (9)
Chiral (S)-BINOL-phosphates: Design, synthesis and their antibacterial and α-glucosidase inhibition studies
- Open Access
- 31 May 2024
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 36 (6) , 1308-1314
Magnesium Sulfide Nanoparticles of Hordeum vulgare: Green Synthesis and their Nano-nutrient Impact on Seed Priming Effect, Germination, Root and Shoot Length of Brassica nigra and Trigonella foenum-graecum
This work describes the green synthesis of magnesium sulfide nanoparticles (MgS NPs) using an extract from Hordeum vulgare leaves and characterized by X-ray diffraction (XRD), UV-visible spectroscopy and scanning electron microscopy (SEM) techniques. The MgS NPs generated were spherical and had a high level of purity. They had a band gap of 2.0 eV, a uniform distribution and an average crystal size of 14 nm. The synthesized MgS nanoparticles exhibited several geometrical morphologies, including spherical, rod-shaped and bean-shaped structures. The nanoparticles exhibited an average size of 5 nm with a band gap of precisely 4.85 eV. The efficacy of MgS NPs on Brassica nigra and Trigonella foenum-graecum for seed priming, germination rate and time, root length and shoot length has also been assessed using different doses. The optimal germination occurs at concentrations of 15 mg/100 mL and 20 mg/100 mL, while the germination is impeded when the concentration exceed 30 mg/100 mL. The MgS NPs exhibit a diminutive size and high reactivity, which allows them to augment the water absorption and nutrient control capacities of seeds. Consequently, this promotes the germination process and plant growth by decreasing the average duration of germination. Seeds of Brassica nigra and Trigonella foenum-graecum that had been subjected to treatment with MgS NPs had enhanced average root and shoot lengths, as well as accelerated germination. This study suggests several possibilities for using environmental friendly nanotechnology to improve agricultural practices.
- 31 May 2024
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 36 (6) , 1308-1314
Open AccessMagnesium Sulfide Nanoparticles of Hordeum vulgare: Green Synthesis and their Nano-nutrient Impact on Seed Priming Effect, Germination, Root and Shoot Length of Brassica nigra and Trigonella foenum-graecum
This work describes the green synthesis of magnesium sulfide nanoparticles (MgS NPs) using an extract from Hordeum vulgare leaves and characterized by X-ray diffraction (XRD), UV-visible spectroscopy and scanning electron microscopy (SEM) techniques. The MgS NPs generated were spherical and had a high level of purity. They had a band gap of 2.0 eV, a uniform distribution and an average crystal size of 14 nm. The synthesized MgS nanoparticles exhibited several geometrical morphologies, including spherical, rod-shaped and bean-shaped structures. The nanoparticles exhibited an average size of 5 nm with a band gap of precisely 4.85 eV. The efficacy of MgS NPs on Brassica nigra and Trigonella foenum-graecum for seed priming, germination rate and time, root length and shoot length has also been assessed using different doses. The optimal germination occurs at concentrations of 15 mg/100 mL and 20 mg/100 mL, while the germination is impeded when the concentration exceed 30 mg/100 mL. The MgS NPs exhibit a diminutive size and high reactivity, which allows them to augment the water absorption and nutrient control capacities of seeds. Consequently, this promotes the germination process and plant growth by decreasing the average duration of germination. Seeds of Brassica nigra and Trigonella foenum-graecum that had been subjected to treatment with MgS NPs had enhanced average root and shoot lengths, as well as accelerated germination. This study suggests several possibilities for using environmental friendly nanotechnology to improve agricultural practices.
- 19 December 2023
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (1) , e202301392
Indolyl‐4H‐Chromene Derivatives as Antibacterial Agents: Synthesis, in Vitro and in Silico Studies
In this study, indolyl‐4H‐chromene derivatives are designed and synthesised using an eco‐friendly multicomponent one‐pot synthesis using benzaldehydes, nitroketene N, S‐acetals, and indoles combine with InCl3, a Lewis acid catalyst, and ethanol, an environmentally acceptable solvent. Due to antibiotic resistance, assessed these Indolyl‐4H‐chromene derivatives for their in vitro antibacterial activity against Gram‐positive and Gram‐negative bacteria, including Streptococcus pyogenes, Staphylococcus aureus, Clostridium pyrogenes, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa, using the agar well diffusion method and Minimum Inhibition Concentration (MIC) assay. Three compounds, 4‐(1H‐indol‐3‐yl)‐6‐methoxy‐N‐methyl‐3‐nitro‐4H‐chromen‐2‐amine, 4‐(1H‐indol‐3‐yl)‐3‐nitro‐N‐phenyl‐4H‐chromen‐2‐amine and 4‐(6‐Fluoro‐1H‐Indol‐3‐yl)‐N‐methyl‐3‐nitro‐4H‐chromen‐2‐amine showed better zone of inhibition (mm) and Minimum Inhibition Concentration (MIC) values of 10 μg/mL to 25 μg/mL against all bacterial types. The Ki values of 278.60 nM and 2.21 nM for compound 4‐(1H‐indol‐3‐yl)‐3‐nitro‐N‐phenyl‐4H‐chromen‐2‐amine showed improved interactions with DNA gyrase B and topoIV ParE′s ATP binding sites in in silico studies.
- 19 December 2023
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (1) , e202301392
Indolyl‐4H‐Chromene Derivatives as Antibacterial Agents: Synthesis, in Vitro and in Silico Studies
In this study, indolyl‐4H‐chromene derivatives are designed and synthesised using an eco‐friendly multicomponent one‐pot synthesis using benzaldehydes, nitroketene N, S‐acetals, and indoles combine with InCl3, a Lewis acid catalyst, and ethanol, an environmentally acceptable solvent. Due to antibiotic resistance, assessed these Indolyl‐4H‐chromene derivatives for their in vitro antibacterial activity against Gram‐positive and Gram‐negative bacteria, including Streptococcus pyogenes, Staphylococcus aureus, Clostridium pyrogenes, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa, using the agar well diffusion method and Minimum Inhibition Concentration (MIC) assay. Three compounds, 4‐(1H‐indol‐3‐yl)‐6‐methoxy‐N‐methyl‐3‐nitro‐4H‐chromen‐2‐amine, 4‐(1H‐indol‐3‐yl)‐3‐nitro‐N‐phenyl‐4H‐chromen‐2‐amine and 4‐(6‐Fluoro‐1H‐Indol‐3‐yl)‐N‐methyl‐3‐nitro‐4H‐chromen‐2‐amine showed better zone of inhibition (mm) and Minimum Inhibition Concentration (MIC) values of 10 μg/mL to 25 μg/mL against all bacterial types. The Ki values of 278.60 nM and 2.21 nM for compound 4‐(1H‐indol‐3‐yl)‐3‐nitro‐N‐phenyl‐4H‐chromen‐2‐amine showed improved interactions with DNA gyrase B and topoIV ParE′s ATP binding sites in in silico studies.
- Open Access
Molecular Hybrids of Pyazolo[3,4-b]pyridine and Triazole: Design, Synthesis and In Vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren’t enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. aureus and K. pneumoniae. The compounds 24 and 27 have been identified as the high potential molecules in this series based on in vitro experiments. Compound 24 has zone of inhibition values of 15 ± 0.82 mm and 14 ± 0.7 mm, whilst compound 27 has zone of inhibition values of 18 ± 0.95 mm and 16 ± 0.82 mm against S. aureus and K. pneumoniae, respectively. MIC and MIB values for compounds 24 and 27 against S. aureus and K. pneumoniae are 0.25 and 0.5, respectively.
Open AccessMolecular Hybrids of Pyazolo[3,4-b]pyridine and Triazole: Design, Synthesis and In Vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren’t enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. aureus and K. pneumoniae. The compounds 24 and 27 have been identified as the high potential molecules in this series based on in vitro experiments. Compound 24 has zone of inhibition values of 15 ± 0.82 mm and 14 ± 0.7 mm, whilst compound 27 has zone of inhibition values of 18 ± 0.95 mm and 16 ± 0.82 mm against S. aureus and K. pneumoniae, respectively. MIC and MIB values for compounds 24 and 27 against S. aureus and K. pneumoniae are 0.25 and 0.5, respectively.
- Open Access
- 11 October 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (45) , 29253-29290
1,4-Dihydropyridine: synthetic advances, medicinal and insecticidal properties
1,4-Dihydropyridine (1,4-DHP) is one of the foremost notable organic scaffolds with diverse pharmaceutical applications.
- 11 October 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (45) , 29253-29290
Open Access1,4-Dihydropyridine: synthetic advances, medicinal and insecticidal properties
1,4-Dihydropyridine (1,4-DHP) is one of the foremost notable organic scaffolds with diverse pharmaceutical applications.
- Open Access
- 29 August 2022
- Published by MDPI AG in Preprints.org
Molecular Hybrids of Pyrazolo[3,4-b]Pyridine and Triazole: Design, Synthesis and in vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren't enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. Aureus and K. Pneumoniae. The compounds CY-R2-25 and CY-R2-28 have been identified as the high potential molecules in this series based on in vitro experiments. CY-R2-25 has zone of inhibition values of 15 0.82 and 14 0.7, whilst CY-R2-28 has the zone of inhibition values of 18 0.95 and 16 0.82 against S. Aureus and K. Pneumoniae, respectively. MIC and MIB values for CY-R2-25 and CY-R2-28 against S. Aureus and K. Pneumoniae are 0.25 and 0.5, respectively.
- 29 August 2022
- Published by MDPI AG in Preprints.org
Open AccessMolecular Hybrids of Pyrazolo[3,4-b]Pyridine and Triazole: Design, Synthesis and in vitro Antibacterial Studies
Antimicrobial resistance is on the rise, and there aren't enough new treatments to combat it. This might send the modern world back to the pre-antibiotic age. The molecular hybrids of pyrazolo[3,4-b]pyridine and triazole have been designed, synthesized, and analyzed for their drug-like molecule nature and in vitro analyses for their inhibition potentials against S. Aureus and K. Pneumoniae. The compounds CY-R2-25 and CY-R2-28 have been identified as the high potential molecules in this series based on in vitro experiments. CY-R2-25 has zone of inhibition values of 15 0.82 and 14 0.7, whilst CY-R2-28 has the zone of inhibition values of 18 0.95 and 16 0.82 against S. Aureus and K. Pneumoniae, respectively. MIC and MIB values for CY-R2-25 and CY-R2-28 against S. Aureus and K. Pneumoniae are 0.25 and 0.5, respectively.
- 5 May 2020
- Published by Wiley in Archiv der Pharmazie
- Vol. 353 (7) , e2000003
(E)‐2‐(2‐Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies
By understanding the rampant infections of Mycobacterium tuberculosis (Mtb) and inflammations caused due to the generation of radical species during the Mtb infection, a series of (E)‐2‐(2‐allylidenehydrazinyl)thiazole derivatives, with dual‐action properties, was designed. The molecules were designed with a considerable variation in LogP, one of the critical parameters in physicochemical properties, and analyzed for their drug‐likeness. For the synthesis, a simple, green, and multicomponent one‐pot synthesis method was developed. The in vitro inhibition potentials were evaluated against Mtb H37Rv by the microplate Alamar Blue assay. The results reveal that compound 6 was potent, with a MIC value of 6.5 µg/ml, and showed better interactions with the KasA protein with binding free energy (ΔG) of −9.4 kcal/mol. Also, the radical scavenging properties were studied to establish the dual‐action properties of the molecules. Compound 9 exhibited promising antioxidant and nitric oxide radical scavenging activities, with 81.7% and 81.0%, respectively, at 1,000‐μg/ml concentration.
- 5 May 2020
- Published by Wiley in Archiv der Pharmazie
- Vol. 353 (7) , e2000003
(E)‐2‐(2‐Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies
By understanding the rampant infections of Mycobacterium tuberculosis (Mtb) and inflammations caused due to the generation of radical species during the Mtb infection, a series of (E)‐2‐(2‐allylidenehydrazinyl)thiazole derivatives, with dual‐action properties, was designed. The molecules were designed with a considerable variation in LogP, one of the critical parameters in physicochemical properties, and analyzed for their drug‐likeness. For the synthesis, a simple, green, and multicomponent one‐pot synthesis method was developed. The in vitro inhibition potentials were evaluated against Mtb H37Rv by the microplate Alamar Blue assay. The results reveal that compound 6 was potent, with a MIC value of 6.5 µg/ml, and showed better interactions with the KasA protein with binding free energy (ΔG) of −9.4 kcal/mol. Also, the radical scavenging properties were studied to establish the dual‐action properties of the molecules. Compound 9 exhibited promising antioxidant and nitric oxide radical scavenging activities, with 81.7% and 81.0%, respectively, at 1,000‐μg/ml concentration.